Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Letendre

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
Neurology|May 13, 2014
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R Franklin, Reena Deutsch, et al.
Journal of Neurovirology|May 6, 2011
Clinical factors related to brain structure in HIV: the CHARTER studyTerry L Jernigan, Sarah L Archibald, Christine Fennema-Notestine, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 28, 2017
Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group studyPeilin Jia, Zhongming Zhao, Todd Hulgan, et al.
Open Forum Infectious Diseases|October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 WeeksJonathan C Reed, Luke Hall, Ashley McKhann, et al.
Journal of Neurovirology|July 11, 2013
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionChristine Fennema-Notestine, Ronald J Ellis, Sarah L Archibald, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
Neurology|May 13, 2014
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R Franklin, Reena Deutsch, et al.
Journal of Neurovirology|May 6, 2011
Clinical factors related to brain structure in HIV: the CHARTER studyTerry L Jernigan, Sarah L Archibald, Christine Fennema-Notestine, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 28, 2017
Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group studyPeilin Jia, Zhongming Zhao, Todd Hulgan, et al.
Open Forum Infectious Diseases|October 27, 2025
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 WeeksJonathan C Reed, Luke Hall, Ashley McKhann, et al.
Journal of Neurovirology|July 11, 2013
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionChristine Fennema-Notestine, Ronald J Ellis, Sarah L Archibald, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Journal of Neurovirology|December 22, 2010
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsRobert K Heaton, Donald R Franklin, Ronald J Ellis, et al.
Pageof 25